Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ray

Showing results (401-410 of 731) with videos related to

Pageof 74
Sort By:
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 22, 2014
The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosusJohn A Reynolds, David W Ray, Leo A H Zeef, et al.
Hepatology Communications|October 4, 2024
Infections in decompensated cirrhosis: Pathophysiology, management, and research agendaJessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 17, 2024
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood typeMiho Akabane, Yuki Bekki, Yosuke Inaba, et al.
Biomed Research International|June 20, 2024
Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisW Ray Kim, Karthik Raghunathan, Greg S Martin, et al.
Gastroenterology|February 22, 2011
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantationMichael D Leise, W Ray Kim, Walter K Kremers, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Nature Communications|September 14, 2017
Misalignment with the external light environment drives metabolic and cardiac dysfunctionAlexander C West, Laura Smith, David W Ray, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiationSarwa Darwish Murad, Julie K Heimbach, Gregory J Gores, et al.
Environmental Toxicology and Chemistry|May 25, 2007
Effects of using synthetic sea salts when measuring and modeling copper toxicity in saltwater toxicity testsW Ray Arnold, Jeffrey S Cotsifas, Anna R Winter, et al.
Pageof 74

Showing results (401-410 of 731) with videos related to

Sort By:
Pageof 74
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 22, 2014
The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosusJohn A Reynolds, David W Ray, Leo A H Zeef, et al.
Hepatology Communications|October 4, 2024
Infections in decompensated cirrhosis: Pathophysiology, management, and research agendaJessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 17, 2024
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood typeMiho Akabane, Yuki Bekki, Yosuke Inaba, et al.
Biomed Research International|June 20, 2024
Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisW Ray Kim, Karthik Raghunathan, Greg S Martin, et al.
Gastroenterology|February 22, 2011
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantationMichael D Leise, W Ray Kim, Walter K Kremers, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Nature Communications|September 14, 2017
Misalignment with the external light environment drives metabolic and cardiac dysfunctionAlexander C West, Laura Smith, David W Ray, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiationSarwa Darwish Murad, Julie K Heimbach, Gregory J Gores, et al.
Environmental Toxicology and Chemistry|May 25, 2007
Effects of using synthetic sea salts when measuring and modeling copper toxicity in saltwater toxicity testsW Ray Arnold, Jeffrey S Cotsifas, Anna R Winter, et al.
Pageof 74